Membrane topology influences N‐glycosylation of the prion protein
暂无分享,去创建一个
[1] G. Air,et al. Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Byers,et al. Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern. , 1992, The Journal of biological chemistry.
[3] S. Prusiner,et al. Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system. , 1997, Protein engineering.
[4] N. E. Hansen,et al. A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria. , 1992, European journal of biochemistry.
[5] R. Puertollano,et al. MAL, an integral element of the apical sorting machinery, is an itinerant protein that cycles between the trans-Golgi network and the plasma membrane. , 1999, Molecular biology of the cell.
[6] P E Wright,et al. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] Stanley B. Prusiner,et al. Scrapie prion protein contains a phosphatidylinositol glycolipid , 1987, Cell.
[8] R. Dwek,et al. The glycan processing and site occupancy of recombinant Thy-1 is markedly affected by the presence of a glycosylphosphatidylinositol anchor. , 1999, Glycobiology.
[9] M. Passos-Bueno,et al. Familial spongiform encephalopathy associated with a novel prion protein gene mutation , 1997, Annals of neurology.
[10] Lei Wei,et al. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. , 1991, The Journal of biological chemistry.
[11] S. Ferrari,et al. Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.
[12] N. Hooper,et al. Ectoenzymes of the kidney microvillar membrane. Affinity purification, characterization and localization of the phospholipase C-solubilized form of renal dipeptidase. , 1989, The Biochemical journal.
[13] F. Cohen,et al. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[14] Andrew F. Hill,et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.
[15] P. Lansbury,et al. Cell-free formation of protease-resistant prion protein , 1994, Nature.
[16] P Corvol,et al. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Prusiner,et al. Cholesterol Depletion and Modification of COOH-Terminal Targeting Sequence of the Priori Protein Inhibit Formation of the Scrapie Isoform , 2002 .
[18] C. Bostock,et al. Characterization and polyanion-binding properties of purified recombinant prion protein. , 1999, The Biochemical journal.
[19] A. Varki,et al. Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.
[20] J. Bangs,et al. Expression of bloodstream variant surface glycoproteins in procyclic stage Trypanosoma brucei: role of GPI anchors in secretion , 1997, The EMBO journal.
[21] S. Kornfeld,et al. Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.
[22] N. Hooper,et al. Comparison of the glycosyl-phosphatidylinositol cleavage/attachment site between mammalian cells and parasitic protozoa. , 2000, Journal of cell science.
[23] H. Wiśniewski,et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.
[24] B. Ghetti,et al. Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Naim,et al. Intracellular Folding of Tissue-type Plasminogen Activator , 1995, The Journal of Biological Chemistry.
[26] A Helenius,et al. How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. , 1994, Molecular biology of the cell.
[27] S. Prusiner,et al. Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Aebi,et al. Yeast Gpi8p is essential for GPI anchor attachment onto proteins. , 1996, The EMBO journal.
[29] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[30] S. Prusiner,et al. Transmissible and genetic prion diseases share a common pathway of neurodegeneration , 1999, Nature.
[31] D. Brown,et al. Mechanism of membrane anchoring affects polarized expression of two proteins in MDCK cells. , 1989, Science.
[32] G. Hart,et al. Rapid processing of the carboxyl terminus of a trypanosome variant surface glycoprotein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Howell,et al. A cleavable N-terminal signal peptide is not a prerequisite for the biosynthesis of glycosylphosphatidylinositol-anchored proteins. , 1994, The Journal of biological chemistry.
[34] M. Turner,et al. The membrane form of variant surface glycoproteins of Trypanosoma brucei , 1983, Nature.
[35] J. Lippincott-Schwartz,et al. Brefeldin A: insights into the control of membrane traffic and organelle structure , 1992, The Journal of cell biology.
[36] J. Bangs,et al. Glycosylphosphatidylinositol-dependent secretory transport in Trypanosoma brucei. , 1998, The Biochemical journal.
[37] K Wüthrich,et al. NMR characterization of the full‐length recombinant murine prion protein, mPrP(23–231) , 1997, FEBS letters.
[38] S. Ball,et al. A role for protein kinase C subtypes α and ε in phorbol-ester-enhanced K+- and carbachol-evoked noradrenaline release from the human neuroblastoma SH-SY5Y , 1994 .
[39] S. Prusiner,et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Prusiner,et al. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[41] N. Hooper,et al. Proteolytic fragmentation of the murine prion protein: role of Tyr‐128 and His‐177 , 1999, FEBS letters.
[42] D. Harris,et al. Blockade of Glycosylation Promotes Acquistion of Scrapie-like Properties by the Prion Protein in Cultured Cells* , 1997, The Journal of Biological Chemistry.
[43] S. Williams,et al. Analysis of the signal for attachment of a glycophospholipid membrane anchor , 1989, The Journal of cell biology.
[44] A. Burlingame,et al. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. , 1999, Biochemistry.